drugset / Trial / NCT00675727
Safety Study of CADI-05 in Patients With Advanced Stage Melanoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study examines the safety of treating patients with advanced stage melanoma with the vaccine CADI-05. In addition, preliminary data regarding the clinical response and immune response will be collected.
Timeline
- Start
- 2006-12
- Primary completion
- 2010-12
- Completion
- —
Outcome
Outcome not reported
Stopped: “DSMB reviewed data of 1st 10 subjects; determined no safety concerns. Efficacy as a single agent in this patient population was unlikely. Voluntary Termination”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CADI-05 | Vaccine | — | Other |